By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Interim Data from IIS Study Shows 75% Response Rate and Three Complete Responses On April 14, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced interim data from the ongoing, open label, investigator-initiated study (IIS) of HyBryte (synthetic hypericin) treatment for up to 54 weeks in … Read more
Austin, TX, USA, April 7, 2025, CyberNewswire — SpyCloud, the leading identity threat protection company, today released new analysis of its recaptured darknet data repository that shows threat actors are increasingly bypassing endpoint protection solutions: 66% of malware infections occur on devices with endpoint security solutions installed. SpyCloud offers integrations with leading endpoint detection and … Read more
Over the course of his long career, magician and endurance performer David Blaine has taken on all kinds of death-defying feats: catching a bullet in his teeth, fasting for 44 days, or holding his breath for a record-breaking 17 minutes and 4 seconds, to name a few. Viewers will get to see a different side … Read more
Austin, TX, Ma. 19, 2025, CyberNewswire — The average corporate user now has 146 stolen records linked to their identity, an average 12x increase from previous estimates, reflecting a surge in holistic identity exposures. SpyCloud, the leading identity threat protection company, today released its 2025 SpyCloud Annual Identity Exposure Report, highlighting the rise of darknet-exposed … Read more
By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. … Read more